20.65
-0.72%
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Bioptik Technology
Its shares trade on Taipei Exchange under the ticker 4161.TWO. It has been listed since 29 July 2011. In the fiscal year to 31 December 2025, it reported revenue of TWD 837.2m and net income of TWD 71.2m. At that date it held total assets of TWD 1.57bn and shareholders' equity of TWD 969.4m.
Bioptik Technology, Inc. engages in the research and development, manufacture, and sale of hyaluronic acid and skincare product. The company is headquartered in Jhunan, Miaoli. The company went IPO on 2011-07-29. The firm mainly provides multifunctional detectors of blood sugar, cholesterol and uric acid, multifunctional detectors of blood sugar, cholesterol, uric acid and heme, as well as blood sugar, cholesterol, uric acid and heme testing paper products, among others. The firm distributes its medical equipment under the brand names of Easy Mate and Easy Touch. The firm also offers biological and medical cosmetics, including toning lotions, essences, facial masks and face cleaning products. Its cosmetic products are distributed under the brand name of ACUREAL. The firm distributes its products within the domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 29 Jul 2011
- Website
- bioptik.com.tw ↗
Leadership
Pay as last reported
- Mr. Chin Chang YangChairman of the Board, General Manager, since 1990
- Mr. Yao Jen TuCo-Chief Executive Officer-Zhuke
- Yiling YangCo-Chief Executive Officer
- Qiaoyun XuHead of Finance & Accounting
- Yihong YangCorporate Governance Officer
- Ms. Lisi CaiDirector
- Mr. Wenxiang CaiDirector
- Mr. Yicheng ChenDirector
- Mr. Duen-Jen ChengDirector
- Mr. Shen-Lung WangDirector
- Mr. Ching-Jang WenDirector
- Mr. Kunlie WuDirector, since 1990
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Bioptik Technology Inc. develops multifunctional blood sugar and cholesterol detectors in TW.
- ACUREAL skincare products are distributed in domestic and overseas markets.
- Easy Mate and Easy Touch medical equipment brands are well-established in Health Care sector.
Weaknesses
- Jhunan, Miaoli headquarters location limits international expansion opportunities.
- Bioptik Technology Inc. focuses on domestic market for medical equipment sales.
- The company's product range is limited to hyaluronic acid and skincare products.
Opportunities
- Expanding into the Health Care sector in Southeast Asia offers growth potential.
- Increasing demand for blood sugar testing products in TW can boost sales.
- The cosmetic segment ACUREAL can be expanded into new markets.
Threats
- Competition from established Health Care companies in TW poses a challenge.
- Regulatory changes in Health Care industry may affect product approvals.
- Overreliance on domestic market sales could lead to revenue instability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.